FIELD: medicine. SUBSTANCE: invention relates to acylated derivatives of enzymes - 4-(N,N,N-trimethylamino)-cinnamoyl derivatives of fibrinolytic enzymes: urokinase, plasminogen and plasmin tissue activators, activating complexes of plasmin-and plasminogen-streptokinase. Method of preparing these acylated derivatives of enzymes involves acylation of fibrinolytic enzymes by serine residue in an active center with an excess of 4-(N,N,N-trimethylamino)-cinnamic acid 4-nitrophenyl ester. Acylation is carried out at 0-25 C and pH 7.0-8.5 for 10-70 min in the absence of an organic solvent. The obtained acylenzymes are separated from unreacted acylating agent and the formed 4-nitrophenyl ester by gel-filtration or ultrafiltration and protein fractions are lyophilized. The prepared agents can be used for treatment of patients with thromboembolic diseases. EFFECT: improved method of preparing. 2 cl, 1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
SOLUBLE FIBRIN MONOMER PREPARATION METHOD | 2003 |
|
RU2253474C1 |
METHOD FOR DETERMINING TISSULAR PLASMINOGEN ADJUVANT | 2003 |
|
RU2252421C1 |
BIFUNCTIONAL VARIANT OF UROKINASE, PLASMID CONTAINING SYNTHETIC STRUCTURAL GENE ENCODING BIFUNCTIONAL UROKINASE, PLASMID (VARIANTS), METHOD OF PLASMID PREPARING, METHOD OF BIFUNCTIONAL VARIANT OF UROKINASE PREPARING, THROMBOLYTIC AGENT | 1994 |
|
RU2143490C1 |
METHOD OF PRODUCTION OF PLASMINOGEN ACTIVATOR | 2007 |
|
RU2346983C1 |
METHOD FOR PLASMINOGENE ACTIVATION | 0 |
|
SU564334A1 |
METHOD FOR ASSESSING THE THROMBOLYTIC POTENTIAL OF MICROMYCETES | 2020 |
|
RU2788697C2 |
USING MATRIC METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTIC THERAPY | 2008 |
|
RU2489163C2 |
RECOMBINANT POLYPEPTIDE WITH HUMAN PLASMINOGEN PROPERTIES TO CONVERT INTO PLASMIN IF ACTIVATED WHICH CATALYSES FIBRIN SPLITTING, DNA FRAGMENT CODING POLYPEPTIDE, RECOMBINANT PLASMID DNA FOR POLYPEPTIDE EXPRESSION AND TRANSFORMED Escherichia coli CELL - POLYPEPTIDE PRODUCER | 2009 |
|
RU2432396C2 |
PLASMINOGEN UROKINASE TYPE MODIFIED ACTIVATOR, DNA SEQUENCE, RECOMBINANT PLASMID, STRAIN-PRODUCER, METHOD FOR PREPARING PLASMINOGEN UROKINASE TYPE MODIFIED ACTIVATOR AND PHARMACEUTICAL COMPOSITION ELICITING THROMBOLYTIC EFFECT | 2001 |
|
RU2247777C2 |
RECOMBINANT POLYPEPTIDE WITH HUMAN PLASMINOGEN PROPERTIES TO CONVERT INTO PLASMIN IF ACTIVATED WHICH CATALYSES FIBRIN SPLITTING, DNA FRAGMENT CODING POLYPEPTIDE, RECOMBINANT PLASMID DNA FOR POLYPEPTIDE EXPRESSION AND TRANSFORMED Escherichia coli CELL - POLYPEPTIDE PRODUCER | 2009 |
|
RU2432397C2 |
Authors
Dates
1998-11-10—Published
1995-09-08—Filed